Unlike full-length growth hormone, which can stimulate appetite through IGF-1 production and growth hormone receptor activation, AOD-9604 does not activate the growth hormone/IGF-1 pathway
Professional peptide therapy begins with comprehensive evaluation to determine which peptides align with your health goals and current status
Its symptoms progress quickly, within months, leading to death within a year of onset
However, for musculoskeletal and systemic applications, subcutaneous injection delivers the peptide directly into systemic circulation at predictable concentrations
In muscles, satellite cells (stem- like progenitors nestled under the basal lamina) activate, sensing damage via signals like hepatocyte growth factor (HGF), HIF1 alpha, or eNOS
Concentration: 500 mcg per capsule